A promising new treatment to combat "undruggable" cancers has been green-lit for a human trial in 2025. It's hoped the novel ...

Regulatory authorities issued precautionary recommendations following the ORAL Surveillance trial, which demonstrated an ...

Gentle on aging skin and powerful on persistent breakouts, this new pharmaceutical option is perfect for women battling ...

Approval was based on results from the Phase II TRUST-I and TRUST-II trials, which demonstrated confirmed overall response rates of up to 90% in patients treated with Ibtrozi for locally advanced or ...